Evidence map›Paper›PMID 25547291›Full record

ArticleMolecular and cellular biology2015

Distinct amino acid compositional requirements for formation and maintenance of the [PSI⁺] prion in yeast.

Kyle S MacLea, Kacy R Paul, Zobaida Ben-Musa, Aubrey Waechter, Jenifer E Shattuck, Margaret Gruca, Eric D Ross

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Biomolecules · 2025
    Article
  3. How Big Is the Yeast Prion Universe?International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Amino acid composition predicts prion activity.PLoS computational biology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kyle S MacLeaDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Kacy R PaulDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Zobaida Ben-MusaGraduate Program in Cell and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Aubrey WaechterDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Jenifer E ShattuckDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Margaret GrucaDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Eric D RossDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA Graduate Program in Cell and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA Eric.Ross@ColoState.Edu.
Colorado State University · US

Funding

The determinants of aggregation and toxicity of prion-like domainsR01GM105991 · NIGMS · COLORADO STATE UNIVERSITY · PI ROSS, ERIC D · 2013 to 2017
$1.5M
NIGMS NIH HHS GM105991NIGMS NIH HHS R01 GM105991
6 · The paper itself

Abstract

Multiple yeast prions have been identified that result from the structural conversion of proteins into a self-propagating amyloid form. Amyloid-based prion activity in yeast requires a series of discrete steps. First, the prion protein must form an amyloid nucleus that can recruit and structurally convert additional soluble proteins. Subsequently, maintenance of the prion during cell division requires fragmentation of these aggregates to create new heritable propagons. For the Saccharomyces cerevisiae prion protein Sup35, these different activities are encoded by different regions of the Sup35 prion domain. An N-terminal glutamine/asparagine-rich nucleation domain is required for nucleation and fiber growth, while an adjacent oligopeptide repeat domain is largely dispensable for prion nucleation and fiber growth but is required for chaperone-dependent prion maintenance. Although prion activity of glutamine/asparagine-rich proteins is predominantly determined by amino acid composition, the nucleation and oligopeptide repeat domains of Sup35 have distinct compositional requirements. Here, we quantitatively define these compositional requirements in vivo. We show that aromatic residues strongly promote both prion formation and chaperone-dependent prion maintenance. In contrast, nonaromatic hydrophobic residues strongly promote prion formation but inhibit prion propagation. These results provide insight into why some aggregation-prone proteins are unable to propagate as prions.

Indexed as

Amino AcidsAmino Acid SequenceAmyloidGene LibraryMolecular Sequence DataMutationOligopeptidesPeptide Termination FactorsPrionsProtein DenaturationProtein FoldingProtein Structure, SecondaryProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTyrosineAmino AcidsAmyloidOligopeptidesPeptide Termination FactorsPrionsSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiaeTyrosine

Identifiers

PMID25547291
PMCPMC4323492
OpenAlexW2035928222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.